FDA Adverse Event Injury Summary report: N

POWERPICC, 3CG

MDR report key: 22248256 · Received June 17, 2025

Report

Report Number
3006260740-2025-03976
Event Type
Injury
Date Received
June 17, 2025
Date of Event
May 15, 2025
Report Date
July 1, 2025
Manufacturer
C.R. BARD, INC. (BASD) -3006260740
Product Code
LJS
UDI-DI
00801741138966
PMA / PMN Number
K091324
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

H11: SECTION A THROUGH F - THE INFORMATION PROVIDED BY BD REPRESENTS ALL OF THE KNOWN INFORMATION AT THIS TIME. DESPITE GOOD FAITH EFFORTS TO OBTAIN ADDITIONAL INFORMATION, THE COMPLAINANT / REPORTER WAS UNABLE OR UNWILLING TO PROVIDE ANY FURTHER PATIENT, PRODUCT, OR PROCEDURAL DETAILS TO BD. THE MANUFACTURER HAS RECEIVED THE SAMPLE AND WILL BE EVALUATED. A SUPPLEMENTAL WILL BE SUBMITTED WITH EVALUATION RESULTS.

Additional Manufacturer Narrative · 0

H11: SECTION A THROUGH F - THE INFORMATION PROVIDED BY BD REPRESENTS ALL OF THE KNOWN INFORMATION AT THIS TIME. DESPITE GOOD FAITH EFFORTS TO OBTAIN ADDITIONAL INFORMATION, THE COMPLAINANT/REPORTER WAS UNABLE OR UNWILLING TO PROVIDE ANY FURTHER PATIENT, PRODUCT, OR PROCEDURAL DETAILS TO BD. THE COMPLAINT OF INFECTION AT THE INSERTION SITE IS CONFIRMED; HOWEVER, THE EXACT CAUSE IS UNKNOWN. ONE PHOTOGRAPH OF A 4 FR SINGLE LUMEN POWERPICC WAS RETURNED FOR EVALUATION. AN INITIAL VISUAL OBSERVATION OF THE PHOTOGRAPH SHOWED MILD REDNESS AND SWELLING WERE IN THE AREA SURROUNDING THE IMPLANTATION SITE. WHAT APPEARED TO BE YELLOW-CLEAR FLUID WAS OBSERVED AT THE INSERTION SITE. CONDENSATION WAS OBSERVED UNDER THE PLASTIC FILM DRESSING AT THE MOLDED JOINT. THE OBSERVATIONS INDICATE THE PATIENT LIKELY HAD AN INFECTION. THERE WAS NO SUPPORTING EVIDENCE WHICH DIRECTLY CONCLUDED THAT THE STERILITY OF THE BD DEVICE HAD BEEN COMPROMISED. PATIENT INFECTION CAN OCCUR DUE TO CONTAMINATION OF THE PRODUCT AND/OR INSERTION SITE AT ANY POINT PRIOR TO, DURING, OR FOLLOWING INSERTION AND, CONSEQUENTLY, IDENTIFYING THE SPECIFIC SOURCE OF CONTAMINATION COULD NOT BE INDEPENDENTLY DETERMINED BY BD. THIS COMPLAINT WILL BE RECORDED FOR FUTURE TRENDING AND MONITORING PURPOSES.

Description of Event or Problem · 0

IT WAS REPORTED THE PATIENT DEVELOPED A DISCHARGE AND LYMPHEDEMA ON THE ARM CARRYING THE PICC. PICC CULTURED POSITIVE FOR STAPHYLOCOCCUS AUREUS. THE DEVICE WAS REMOVED AND DISCARDED. A NEW PICC WAS INSERTED. THE PATIENT WAS TREATED WITH ANTIBIOTICS. PATIENT RETURNED HOME ON (B)(6) 2025. CUSTOMER STATES THE DISCHARGE WAS NOT RELATED TO INFUSIONS. NO OTHER INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1650022 POWERPICC, 3CG PERIPHERALLY INSERTED CENTRAL CATHETER (PICC) LJS C.R. BARD, INC. (BASD) -3006260740 N/A REJS1322 00801741138966

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention